POMDOCTOR LIMITED American Depositary Shares (POM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, POMDOCTOR LIMITED American Depositary Shares (POM) has a cash flow conversion efficiency ratio of 0.033x as of March 2020. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.08 Billion) by net assets ($32.48 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see POMDOCTOR LIMITED American Depositary Sh (POM) total market value for the company's overall valuation and market capitalisation.
POMDOCTOR LIMITED American Depositary Shares - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how POMDOCTOR LIMITED American Depositary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data.
POMDOCTOR LIMITED American Depositary Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of POMDOCTOR LIMITED American Depositary Shares ranked by their cash flow conversion efficiency. Explore POMDOCTOR LIMITED American Depositary Sh cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
GoHealth, Inc.
NASDAQ:GOCOQ
|
-0.055x |
|
Betacom S.A.
WAR:BCM
|
0.199x |
|
Biofil Chemicals & Pharmaceuticals Limited
NSE:BIOFILCHEM
|
-0.167x |
|
Ansal Properties & Infrastructure Limited
NSE:ANSALAPI
|
-0.110x |
|
Enquest Plc
LSE:ENQ
|
0.453x |
|
Dlaboratory Sweden AB
ST:DLAB
|
0.162x |
|
Boqii Holding Limited
NYSE:BQ
|
0.002x |
|
Clearmind Medicine Inc. Common Shares
NASDAQ:CMND
|
-0.253x |
Annual Cash Flow Conversion Efficiency for POMDOCTOR LIMITED American Depositary Shares (2003–2025)
The table below shows the annual cash flow conversion efficiency of POMDOCTOR LIMITED American Depositary Shares from 2003 to 2025. View POM stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-481.30 Million | $-148.48 Million | 0.308x | +3906.13% |
| 2024-12-31 | $-2.09 Billion | $-16.13 Million | 0.008x | -67.02% |
| 2023-12-31 | $-1.96 Billion | $-45.80 Million | 0.023x | +101.27% |
| 2022-12-31 | $-1.90 Billion | $-22.02 Million | 0.012x | +31.49% |
| 2021-12-31 | $-1.78 Billion | $-15.68 Million | 0.009x | -92.16% |
| 2020-12-31 | $-309.35 Million | $-34.80 Million | 0.112x | +332.60% |
| 2019-12-31 | $3.27 Billion | $85.00 Million | 0.026x | -90.75% |
| 2018-12-31 | $30.76 Billion | $8.64 Billion | 0.281x | +12.15% |
| 2017-12-31 | $29.86 Billion | $7.48 Billion | 0.251x | -23.35% |
| 2016-12-31 | $25.84 Billion | $8.45 Billion | 0.327x | +53.61% |
| 2015-12-31 | $4.41 Billion | $939.00 Million | 0.213x | +7.69% |
| 2014-12-31 | $4.32 Billion | $854.00 Million | 0.198x | +71.55% |
| 2013-12-31 | $4.32 Billion | $497.00 Million | 0.115x | -13.50% |
| 2012-12-31 | $4.45 Billion | $592.00 Million | 0.133x | -15.84% |
| 2011-12-31 | $4.34 Billion | $686.00 Million | 0.158x | +88.51% |
| 2010-12-31 | $703.00 Million | $59.00 Million | 0.084x | +1966.11% |
| 2009-12-31 | $10.83 Billion | $44.00 Million | 0.004x | -65.59% |
| 2008-12-31 | $11.10 Billion | $131.00 Million | 0.012x | -3.54% |
| 2007-12-31 | $10.38 Billion | $127.00 Million | 0.012x | +77.75% |
| 2006-12-31 | $9.88 Billion | $68.00 Million | 0.007x | +85.86% |
| 2005-12-31 | $9.18 Billion | $34.00 Million | 0.004x | -46.21% |
| 2004-12-31 | $8.28 Billion | $57.00 Million | 0.007x | -66.55% |
| 2003-12-31 | $8.06 Billion | $166.00 Million | 0.021x | -- |
About POMDOCTOR LIMITED American Depositary Shares
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company in involv… Read more